Cognitive behavioural treatment for mild Alzheimer’s patients and their caregivers (CBTAC): study protocol for a randomized controlled trial

BACKGROUND: About 90 % of all persons with mild Alzheimer’s disease experience neuropsychiatric symptoms, most frequently apathy, depression, anxiety and irritability. These symptoms are associated with greater morbidity, a reduced quality of life for the patient, an increased burden and depression...

Descripción completa

Detalles Bibliográficos
Autores principales: Forstmeier, Simon, Maercker, Andreas, Savaskan, Egemen, Roth, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650298/
https://www.ncbi.nlm.nih.gov/pubmed/26576633
http://dx.doi.org/10.1186/s13063-015-1043-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650298/
https://www.ncbi.nlm.nih.gov/pubmed/26576633
http://dx.doi.org/10.1186/s13063-015-1043-0

Ejemplares similares